OX40-OX40L Interaction Promotes Proliferation and Activation of Lymphocytes via NFATc1 in ApoE-Deficient Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yan, Jinchuan ^a   Su, Hongling ^a   Xu, Liangjie ^a   Wang, Cuiping ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; NUCLEAR FACTOR OF ACTIVATED T CELL C1; OX40 LIGAND; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; GENE LOCATION; GENE OVEREXPRESSION; HELPER CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NUCLEAR FACTOR OF ACTIVATED T CELL C1 GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MICE; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; OX40 LIGAND; PLAQUE, ATHEROSCLEROTIC; PROTEIN BINDING; RECEPTORS, OX40; TIME FACTORS;

MUS;

EID: 84876048587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060854     Document Type: Article

References (24)

1. Gotsman I, Sharpe AH, Lichtman AH, (2008) T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220-1231.
2. Van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ, et al. (2007) Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204-210.
3. Liu DM, Yan JC, Wang CP, Chen GH, Ding S, et al. (2008) The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22-26.
4. Hogan PG, Chen L, Nardone J, Rao A, (2003) Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205-2232.
5. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, et al. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
6. Clipstone NA, Crabtree GR, (1992) Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 357: 695-697.
7. Fruman DA, Klee CB, Bierer BE, Burakoff SJ, (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci U S A. 89: 3686-3690.
8. Sieber M, Baumgrass R, (2009) Novel inhibitors of the calcineurin/NFATc hub- alternatives to CsA and FK506. Cell Commun Signal 7: 25.
9. Karpurapu M, Wang D, Singh NK, Li Q, Rao GN, (2008) NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577-26590.
10. Yan J, Wang C, Du R, Liu P, Chen G, (2009) OX40-OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460-464.
11. Xu LJ, Yan JC, Wang B, Liu PJ, Gong J, et al. (2011) Effect of the costimulatory molecules OX40-OX40 ligand interaction on the expression of NFATc1 in leukocytes of apolipoprotein E-deficient mice. Zhonghua Xin Xue Guan Bing Za Zhi 39: 526-530.
12. Yoshioka T, Nakajima A, Akiba H, Ishiwata T, Asano G, et al. (2000) Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol 30: 2815-2823.
13. Macian F, (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.
14. Huber SA, Sakkinen P, David C, Newell MK, Tracy RP, (2001) T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103: 2610-2616.
15. Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, et al. (2001) In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104: 197-202.
16. Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, et al. (2002) Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 32: 2874-2880.
17. Healy AM, Izmailova E, Fitzgerald M, Walker R, Hattersley M, et al. (2006) PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis. J Immunol 177: 1886-1893.
18. Akiba H, Miyahira Y, Atsuta M, Takeda K, Nohara C, et al. (2000) Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leish- maniasis. J Exp Med 191: 375-380.
19. Ishii N, Ndhlovu LC, Murata K, Sato T, Kamanaka M, et al. (2003) OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses. Eur J Immunol 33: 2372-2381.
20. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, et al. (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202: 1213-1223.
21. Lane P, (2000) Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med 191: 201-206.
22. al-Shamkhani A, Birkeland ML, Puklavec M, Brown MH, James W, et al. (1996) OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur J Immunol 26: 1695-1699.
23. Walker LS, Gulbranson-Judge A, Flynn S, Brocker T, Lane PJ, (2000) Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol Today 21: 333-337.
24. Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, et al. (2003) CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J Neuroimmunol 145: 1-11.